NantWorks Competitors and Similar CompaniesClear all
NantWorks's competitors and similar companies include Orchard Therapeutics, Stealth BioTherapeutics, Ambys Medicines and Dxcover.
 NantWorks NantWorks is building an integrated fact-based, genomically-informed, personalized approach to the delivery of care and the development of next generation diagnostics and therapeutics for life threatening diseases. |  Orchard Therapeutics Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy. |  Stealth BioTherapeutics Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction. |  Ambys Medicines Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases. |  Dxcover Dxcover (previously known as ClinSpec Diagnostics) is advancing a blood test that can provide accurate results and potentially improve brain cancer survival rates through earlier detection. | |
Founding Date | Founding Date 2011 | Founding Date 2015 | Founding Date 2007 | Founding Date 2018 | Founding Date 2016 |
Type | Type Private | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Culver City, US HQ | Locations London, GB HQ Boston, US Boston, US Foster City, US Menlo Park, US | Locations Newton, US HQ Needham, US | Locations Redwood City, US HQ South San Francisco, US | Locations Glasgow, GB HQ |
Employees | Employees 66 | Employees 166 | Employees 592% decrease | Employees 14 | Employees 294% increase |
Financial | |||||
Net income | Net income N/A | Net income ($150.7m) (FY, 2022) | Net income ($52.5m) (FY, 2021) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 15m (about 12 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 80m (almost 8 years ago) | Latest funding round $ 1.5m (about 5 years ago) |
Total funding raised | Total funding raised $ 140m | Total funding raised $ 310.7m | Total funding raised $ 100m | Total funding raised $ 140m | Total funding raised $ 6.3m |
For sources of this data, please see the company profile
View Company Profiles
Orchard Therapeutics
HQ
London, GB
Orchard Therapeutics is a biotechnology company that develops transformative ex vivo autologous hematopoietic stem cell gene therapy.
View companyStealth BioTherapeutics
HQ
Newton, US
Employees
59↓ 2% decrease
Stealth BioTherapeutics is a clinical-stage biopharmaceutical company developing investigational drugs for the treatment of diseases involving mitochondrial dysfunction.
View companyAmbys Medicines
HQ
Redwood City, US
Employees
14
Ambys Medicines is a developer of regenerative medicine therapies for serious liver diseases.
View companyDxcover
HQ
Glasgow, GB
Employees
29↑ 4% increase
Dxcover (previously known as ClinSpec Diagnostics) is advancing a blood test that can provide accurate results and potentially improve brain cancer survival rates through earlier detection.
View company